← Back to Clinical Trials
Recruiting NCT03252795

NCT03252795 Uterus Transplantation From a Multi-organ Donor

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT03252795
Status Recruiting
Phase
Sponsor University Hospital, Ghent
Condition Infertility, Female
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2016-11-03
Primary Completion 2027-12-31

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 38 Years
Study Type INTERVENTIONAL
Interventions
uterus transplantation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2016-11-03 with a primary completion date of 2027-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Uterus transplantation: screening, in vitro fertilization \[IVF\] treatment to be able to freeze embryos, uterus transplantation, pregnancy and afterwards removal of the uterus.

Eligibility Criteria

Inclusion Criteria: * Female with Maier-Rokitansky-Kuster-Hauser syndrome * Mucosal neovagina of at least 7 cm * In a stable relationship for at least 1 year * Child wish * Good renal function (and presence of both kidneys) * Psychologically stable and compliant * At least 8 frozen embryos after IVF/intracytoplasmic sperm injection \[ICSI\] * Living in Belgium and a good health insurance * Willing and able to provide informed consent Exclusion Criteria: * Major pelvic surgery * Major chronic illnesses * Other risk factors or malignancies * BMI \> 30

Contact & Investigator

Central Contact

Steven Weyers, MD, PhD

✉ steven.weyers@uzgent.be

📞 +3293325446

Frequently Asked Questions

Who can join the NCT03252795 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 38 Years, studying Infertility, Female. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT03252795 currently recruiting?

Yes, NCT03252795 is actively recruiting participants. Contact the research team at steven.weyers@uzgent.be for enrollment information.

Where is the NCT03252795 trial being conducted?

This trial is being conducted at Ghent, Belgium.

Who is sponsoring the NCT03252795 clinical trial?

NCT03252795 is sponsored by University Hospital, Ghent. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology